These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16619228)

  • 1. The NHLBI Clinical Trials Network in transfusion medicine and hemostasis: an overview.
    Dzik WH
    J Clin Apher; 2006 Apr; 21(1):57-9. PubMed ID: 16619228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining effective therapies in transfusion medicine and hemostasis: new opportunities with the TMH Network.
    Konkle BA; Nemo GJ
    Transfusion; 2005 Sep; 45(9):1404-6. PubMed ID: 16131371
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion recipient epidemiology and outcomes research: possibilities for the future.
    Hillyer CD; Blumberg N; Glynn SA; Ness PM;
    Transfusion; 2008 Aug; 48(8):1530-7. PubMed ID: 18564389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion in Europe: basic principles for initial and continuous training in transfusion medicine: an approach to an European harmonisation.
    Mueller MM; Seifried E
    Transfus Clin Biol; 2006 Nov; 13(5):282-5; quiz 286-9. PubMed ID: 17196864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research programs of the National Heart, Lung, and Blood Institute. Bethesda, Maryland, U.S.A.
    Roth CA; Lenfant C
    Cor Vasa; 1989; 31(2):81-9. PubMed ID: 2743780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward prevention of cardiovascular disease. A 30-year retrospective.
    Levy RI
    Circulation; 1979 Dec; 60(7):1555-9. PubMed ID: 387282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHLBI plans for the promise of cell-based therapies.
    Mondoro TH; Thomas JW; Henslee-Downey PJ; Peterson CM
    Cytotherapy; 2005; 7(4):317-27. PubMed ID: 16162453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside.
    Read EJ
    Cytotherapy; 2004; 6(6):626-8. PubMed ID: 15764029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop.
    Blajchman MA; Carson JL; Eikelboom JW; Heddle NM; Lacroix J; Lauer MS; Platt R; Tilley B; Triulzi D; Vickers AJ; Yusuf S; Glynn S; Mondoro TH; Wagner E
    Transfusion; 2012 Jun; 52(6):1363-78. PubMed ID: 22486525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative National ALS Study Group. Patient orientated research and clinical trials.
    Bradley WG
    J Neurol Sci; 2006 Mar; 242(1-2):71-4. PubMed ID: 16386274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine research and cooperative groups: can it happen?
    O'Mara A
    J Pediatr Oncol Nurs; 2006; 23(5):258-60. PubMed ID: 16902079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.
    Lefer DJ; Bolli R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):332-9. PubMed ID: 21821536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health eliminates funding for national architecture linking primary care research.
    Peterson KA
    J Am Board Fam Med; 2007; 20(2):229-31. PubMed ID: 17341760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial opportunities in Transfusion Medicine: proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium.
    Blajchman MA; Glynn SA; Josephson CD; Kleinman SH;
    Transfus Med Rev; 2010 Oct; 24(4):259-85. PubMed ID: 20851330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
    Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
    J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NHLBI clinical trials workshop: an executive summary.
    Zheng G; Wu CO; Yang S; Waclawiw MA; DeMets DL; Geller NL
    Stat Med; 2012 Nov; 31(25):2938-43. PubMed ID: 22733431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.